NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 324 filers reported holding NEOGENOMICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,090,437 | +28.2% | 1,416,714 | +19.4% | 0.00% | 0.0% |
| Q3 2022 | $10,213,303 | +17.5% | 1,186,214 | +11.2% | 0.00% | +50.0% |
| Q2 2022 | $8,690,321 | -12.7% | 1,066,297 | +30.1% | 0.00% | 0.0% |
| Q1 2022 | $9,954,920 | -64.4% | 819,335 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $27,956,000 | -24.6% | 819,335 | +6.6% | 0.01% | -25.0% |
| Q3 2021 | $37,091,000 | +1.5% | 768,878 | -5.0% | 0.01% | 0.0% |
| Q2 2021 | $36,555,000 | -16.9% | 809,280 | -11.2% | 0.01% | -20.0% |
| Q1 2021 | $43,977,000 | -13.4% | 911,813 | -3.4% | 0.01% | -16.7% |
| Q4 2020 | $50,808,000 | +57.7% | 943,690 | +8.0% | 0.01% | +33.3% |
| Q3 2020 | $32,228,000 | +23.7% | 873,626 | +3.9% | 0.01% | +12.5% |
| Q2 2020 | $26,059,000 | +7.3% | 841,140 | -4.3% | 0.01% | -11.1% |
| Q1 2020 | $24,276,000 | -1.7% | 879,259 | +4.2% | 0.01% | +28.6% |
| Q4 2019 | $24,693,000 | +310.0% | 844,190 | +168.0% | 0.01% | +250.0% |
| Q3 2019 | $6,022,000 | – | 314,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |